FDA Approves First Drug for Friedreich’s Ataxia
Mar 1, 2023
The drug, omaveloxolone, is a once-a-day pill that will help improve neurological function and slow progression of the neurodegenerative disease.
<p>Brachial plexus and peripheral nerve injuries affect the nerves that supply the arms and hands, and include birth-related palsies, trauma and peripheral tumors.</p>
Mar 1, 2023
The drug, omaveloxolone, is a once-a-day pill that will help improve neurological function and slow progression of the neurodegenerative disease.
Feb 28, 2023
Late-onset sepsis is a significant cause of morbidity and mortality among very preterm infants.
Mar 7, 2023
Check out a new infographic highlighting three important points related to aluminum in vaccines, and find links to the updated 2023 immunization schedules.
Mar 7, 2023
In this issue of Parents PACK, we take a closer look at COVID-19 and kids, including disease complications, immunity after natural infection, vaccination rates, and safety of the COVID-19 vaccine.
Feb 21, 2023
Translational findings in new models of SURF1 mitochondrial disease also suggest that two drugs, already FDA-approved for other conditions, may prevent neurological decompensation in Leigh syndrome patients.
Feb 23, 2023
Check out important takeaways from a descriptive analysis of COVID-19 deaths based on WHO data sources. You’ll also find materials from the “We Can Do This” campaign for educating the public about COVID-19.
Feb 23, 2023
Author Mark Bergen takes readers from the idea born by YouTube creators as they sought to invent an internet business in 2005, through 2020 when 500 hours of footage were uploaded every minute.
Feb 23, 2023
Check out info about the CDC’s respiratory viruses dashboards and how they can help you stay up to date.
Feb 23, 2023
Read about a research study comparing the relative efficacy of an oral form of remdesivir with that of Paxlovid for the treatment of COVID-19.
Feb 23, 2023
See if you can answer these trivia questions about the 2023 immunization schedules and find links to the schedules and summaries of changes.